Windlas Biotech Ltd IPO

Last Updated: 14 December 2021 8:07 PM by 5Paisa

Windlas Biotech Limited is amongst the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization (“CDMO”) industry in India in terms of revenue (Source: CRISIL Report). The company manufactures both solid and liquid pharmaceutical dosage forms and has significant experience in providing specialized capabilities, including high potency, controlled substances and low-solubility. Windlas Biotech provide a comprehensive range of CDMO services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics.

Windlass Biotech - Financials